Mike Polark
Stock Analyst at Baird
(2.26)
# 1,502
Out of 5,150 analysts
87
Total ratings
42.11%
Success rate
-0.04%
Average return
Main Sectors:
Stocks Rated by Mike Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Holdings | Maintains: Outperform | $220 → $200 | $127.95 | +56.31% | 14 | Feb 20, 2026 | |
| INSP Inspire Medical Systems | Downgrades: Peer Perform | n/a | $64.32 | - | 11 | Feb 13, 2026 | |
| MDLN Medline | Initiates: Outperform | $47 | $42.88 | +9.61% | 1 | Jan 12, 2026 | |
| EW Edwards Lifesciences | Upgrades: Peer Perform | n/a | $85.22 | - | 5 | Oct 29, 2025 | |
| MDT Medtronic | Upgrades: Peer Perform | n/a | $95.60 | - | 3 | Jun 30, 2025 | |
| BBNX Beta Bionics | Initiates: Outperform | $20 | $11.38 | +75.75% | 1 | May 30, 2025 | |
| LIVN LivaNova | Upgrades: Outperform | $60 | $65.26 | -8.06% | 9 | May 20, 2025 | |
| PODD Insulet | Upgrades: Outperform | $350 | $242.89 | +44.10% | 4 | May 13, 2025 | |
| KMTS Kestra Medical Technologies | Initiates: Outperform | $29 | $22.29 | +30.10% | 1 | Mar 31, 2025 | |
| RMD ResMed | Downgrades: Underperform | $180 | $259.05 | -30.52% | 5 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $95.75 | - | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $405 | $381.89 | +6.05% | 1 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $487 → $503 | $501.18 | +0.36% | 7 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Peer Perform | n/a | $113.10 | - | 4 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Peer Perform | n/a | $119.18 | - | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $121 | $72.90 | +65.98% | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | n/a | $23.41 | - | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $25 | $15.76 | +58.63% | 4 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $165 | $175.37 | -5.91% | 3 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $72.21 | - | 2 | Jul 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $13.95 | -6.81% | 2 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Peer Perform | $21 | $3.94 | +432.99% | 1 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $230 → $250 | $243.07 | +2.85% | 2 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $43 | $1.53 | +2,710.46% | 1 | Sep 2, 2020 |
iRhythm Holdings
Feb 20, 2026
Maintains: Outperform
Price Target: $220 → $200
Current: $127.95
Upside: +56.31%
Inspire Medical Systems
Feb 13, 2026
Downgrades: Peer Perform
Price Target: n/a
Current: $64.32
Upside: -
Medline
Jan 12, 2026
Initiates: Outperform
Price Target: $47
Current: $42.88
Upside: +9.61%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $85.22
Upside: -
Medtronic
Jun 30, 2025
Upgrades: Peer Perform
Price Target: n/a
Current: $95.60
Upside: -
Beta Bionics
May 30, 2025
Initiates: Outperform
Price Target: $20
Current: $11.38
Upside: +75.75%
LivaNova
May 20, 2025
Upgrades: Outperform
Price Target: $60
Current: $65.26
Upside: -8.06%
Insulet
May 13, 2025
Upgrades: Outperform
Price Target: $350
Current: $242.89
Upside: +44.10%
Kestra Medical Technologies
Mar 31, 2025
Initiates: Outperform
Price Target: $29
Current: $22.29
Upside: +30.10%
ResMed
Sep 18, 2024
Downgrades: Underperform
Price Target: $180
Current: $259.05
Upside: -30.52%
Sep 10, 2024
Initiates: Peer Perform
Price Target: n/a
Current: $95.75
Upside: -
Sep 10, 2024
Initiates: Outperform
Price Target: $405
Current: $381.89
Upside: +6.05%
Jul 19, 2024
Maintains: Outperform
Price Target: $487 → $503
Current: $501.18
Upside: +0.36%
Jul 21, 2023
Upgrades: Peer Perform
Price Target: n/a
Current: $113.10
Upside: -
Apr 26, 2023
Downgrades: Peer Perform
Price Target: n/a
Current: $119.18
Upside: -
Jan 26, 2023
Initiates: Outperform
Price Target: $121
Current: $72.90
Upside: +65.98%
Jan 26, 2023
Initiates: Peer Perform
Price Target: n/a
Current: $23.41
Upside: -
Jan 11, 2023
Upgrades: Outperform
Price Target: $25
Current: $15.76
Upside: +58.63%
Sep 15, 2022
Upgrades: Outperform
Price Target: $165
Current: $175.37
Upside: -5.91%
Jul 6, 2022
Initiates: Outperform
Price Target: n/a
Current: $72.21
Upside: -
Apr 6, 2022
Initiates: Outperform
Price Target: $13
Current: $13.95
Upside: -6.81%
Apr 6, 2022
Initiates: Peer Perform
Price Target: $21
Current: $3.94
Upside: +432.99%
Aug 11, 2021
Maintains: Outperform
Price Target: $230 → $250
Current: $243.07
Upside: +2.85%
Sep 2, 2020
Initiates: Neutral
Price Target: $43
Current: $1.53
Upside: +2,710.46%